Donor lung pretreatment with surfactant in experimental transplantation preserves graft hemodynamics and alveolar morphology

Experimental Biology and Medicine

Volumn 228, Issue 5, 2003, Pages 540-545

  Koletsis, E ^a,e   Chatzimichalis, A ^b   Fotopoulos, V ^a   Kokkinis, K ^a   Papadimitriou, E ^c   Tiniakos, D ^d   Marinos, E ^d   Bellenis, I ^b   Dougenis, D ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e NONE   (Greece)

Author keywords

Experimental reperfusion injury; Lung transplantation; Nitric oxide; SP A; Surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; NITRIC OXIDE; SURFACTANT APOPROTEIN A FREE SURFACTANT; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION; LUNG SURFACTANT; NITRITE;

ADOLESCENT; ANIMAL TISSUE; AUTOTRANSPLANTATION; BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; EXPERIMENTAL TRANSPLANTATION; FEMALE; GRAFT PRESERVATION; HISTOPATHOLOGY; LUNG ALVEOLUS; LUNG HEMODYNAMICS; LUNG PARENCHYMA; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MORPHOMETRICS; NONHUMAN; REPERFUSION INJURY; SWINE; TEMPERATURE; ANIMAL; ARTICLE; GRAFT SURVIVAL; HEMODYNAMICS; LUNG; METABOLISM; PATHOLOGY; ANIMAL EXPERIMENT; ANIMAL MODEL; BRONCHOSCOPY; CARDIOPULMONARY FUNCTION; CELL INFILTRATION; COLD ISCHEMIA; HISTOLOGY; PIG; THORACOTOMY;

ANIMALIA; BRONCHUS; SUS SCROFA;

ANIMALS; FEMALE; GRAFT SURVIVAL; HEMODYNAMIC PROCESSES; LUNG; LUNG TRANSPLANTATION; NITRIC OXIDE; PULMONARY SURFACTANTS; REPERFUSION INJURY; SWINE;

EID: 0037868831     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/15353702-0322805-23     Document Type: Conference Paper

References (39)

1. Lewis JFR, Novick J, Veldhuizen RAW. Surfactant in Lung Injury and Lung Transplantation. New York: Chapman & Hall, 1997.
2. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: The importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 62:302-314, 1996.
3. Klepetko W, Lohninger A, Wissen W, Mueller MR, Khunl-Brady G, Windisch A, Eckerberger F, Wolner E. Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: Effect of L-carnitine application. J Thorac. Cardiovasc Surg 99:1048-1058, 1990.
4. Andrade R, Solien E, Wangensteen OD, Tsai MY, Kshettry VR, Bolman RM 3rd. Surfactant dysfunction in lung preservation. Transplantation 60:536-541, 1995.
5. Cockshutt A, Weitz J, Possmayer F. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverse inhibition by blood proteins in vitro. Biochemistry 29:8424-8429, 1990.
6. Kuroki Y, Mason RJ, Voelker DR. Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 263:3388-3394, 1988.
7. Hohlfeld JM, Tiryaki E, Hamm H, Hoymann HG, Krug N, Haverich A, Fabel H. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 158:706-712, 1998.
8. Erasmus ME, Petersen AH, Oetomo SB, Prop J. The function of surfactant is impaired during the reimplantation response in rat lung transplants. J Heart Lung Transplant 13:791-802, 1994.
9. Veldhuizen RA, Lee J, Sandler D, et al. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis 148:208-215, 1993.
10. Dougenis D, Tzorakoelefterakis E, Filos KS, et al. Experimental single lung transplantation in pigs. Intern J Artif Organ 15:533, 1992.
11. 2 monitoring by fiberoptic oxymetry in single lung transplantation. A pilot study. Intens Care Med 18(suppl):117, 1992.
12. Swindell MM. Anesthetic and perioperative techniques in swine. Wilmington, MA: Charles River Laboratories, CRL Tech Bull (winter), 1991.
13. Hawk CT, Leary SL. Formulatory for Laboratory Animals. Iowa: American College of Laboratory Animal Medicine, Iowa State Pr (Sd) p78, 1995.
14. Kouloukoussa M, Panagopoulou E, Marinos E. The in vitro effect of the tumor promoter 12-O-tetradecanoyphorbol-13-acete on Sertoli cell morphology. Cancer Detect Prev 23:280-289, 1999.
15. Pipili-Synetos E, Kritikou S, Papadimitriou E, et al. Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chicken chorioallantoic membrane. Br J Pharmacol 129:207-213:39-78 2000.
16. Carvounis CP. Handbook of biostatistics. A review and text. New York: Parthenon Publishing, 2000.
17. Spragg R, Lewis J. Pathology of the surfactant system of the mature lung. Am J Respir Crit Care Med 163:280-282, 2001.
18. Report of the ATS workshop on lung transplantation: Lung transplantation. Am Rev Resp Dis 147:772-776, 1993.
19. Novick RJ, Menkis AH, McKenzie FN. New trends in lung preservation: A collective review. J Heart Lung Transplant 11:377-392, 1992.
20. Cooper JV, Vreim CE. Biology of lung preservation for transplantation. Am Rev Resp Dis 146:803-807, 1992.
21. Burkhardt R, Van Golde LMG. Lipids and lipid metabolism in the lung. Lung Biol Tzorakoelefterakis E. Health Dis 41:591-599, 1989.
22. Hallman M, Maasilta P, Sipila I, Tahvanainen J. Composition and faction of pulmonary surfactant in adult respiratory distress syndrome. Eur Resp. J 2(Suppl 3):104s-108s, 1989.
23. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck S. Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 70:673-683, 1982.
24. Li CG, Rand MJ. Evidence that part of the NANC relaxant response of the guinea pig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol 102:91-94, 1991.
25. Dinh-Xuan AT. Endothelial modulation of pulmonary vascular tone. Eur Respir J 51:757-762, 1992.
26. Barnes PJ. Nitric oxide and airways. Eur Respir J 6:163-165, 1993.
27. Tsao PS, Lefer AM. Time course and mechanism of endothelial dysfunction is isolated ischemic and hypoxic perfused rat hearts. Am J Physiol 259:H1660-H1666, 1990.
28. Thuchiya M, Tokai H, Takehara Y, et al. Interrelation between oxygen tension and nitric oxide in the respiratory system. Am J Respir Crit Care Med 162:1257-1261, 2000.
29. Dugas B, Debre P, Moncada S. Nitric oxide, a vital poison inside the immune and inflammatory network. Res Immunol 146:664-670, 1995.
30. Hancock JT. Superoxide, hydrogen peroxide and nitric oxide as signaling molecules: Their production and role in disease. Br J Biomed. Sci 54:38-46, 1997.
31. Kubes P, Szuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655, 1991.
32. Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 33:71-90, 1993.
33. Moilanen E, Vapaatalo H. Nitric oxide in inflammation and immune response. Ann Med 27:359-367, 1995.
34. Schroeder RA, Kuo PC. Nitric oxide: Physiology and pharmacology. Anesth Analg 81:1052-1059, 1995.
35. Merritt TA, Hallman M. Surfactant replacement. A new era with many challenges for neonatal medicine. Am J Dis Child 142:1333-1339, 1988.
36. Sano H, Sohma H, Muta T, Nomura S, Voeker DR, Kuroki Y. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD 14. J Immunol 163:387-395, 1999.
37. Kramer B, Jobe A. Surfactant protein A recruits neutrophils into the lungs of ventilated preterm lambs. Am J Respir Crit Care Med 163:158-165, 2001.
38. Awasthi S, Coalson JJ, Yoder BA, Crouch E, King RJ. Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons. Am J Respir Crit Care Med 163:389-397, 2001.
39. Walmrath D, Günther A, Chofrani HA, Schermuly R, Scheider T, Grimminger F, Seeger W. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 154:57-62, 1996.